We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$7.58B
AUM Growth
+$139M
Cap. Flow
+$177M
Cap. Flow %
2.33%
Top 10 Hldgs %
25.49%
Holding
165
New
14
Increased
52
Reduced
27
Closed
13

Top Buys

Rank Stock Value
1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$63.7M
2
FIVN icon
FIVE9
FIVN
+$52.6M
3
XMTR icon
Xometry
XMTR
+$50.4M
4
GLBE icon
Global E Online
GLBE
+$32.3M
5
FVRR icon
Fiverr
FVRR
+$31.6M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$83.1M
2
TRIL
Trillium Therapeutics Inc.
TRIL
+$50M
3
CLDX icon
Celldex Therapeutics
CLDX
+$46M
4
BBIO icon
BridgeBio Pharma
BBIO
+$43.4M
5
RNG icon
RingCentral
RNG
+$39.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.36%
2 Technology 30.11%
3 Industrials 12.97%
4 Consumer Discretionary 7.19%
5 Communication Services 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCXI
101
DELISTED
ChemoCentryx, Inc.
CCXI
$17.8M 0.23%
1,040,000
-363,000
-26% -$5.66M
VECT
102
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$17.6M 0.23%
2,339,044
-2,383
-0.1% -$20.4K
XPO icon
103
XPO
XPO
$23.4B
$17.5M 0.23%
370,260
-265,847
-42% -$13.3M
EPIX
104
DELISTED
ESSA Pharma
EPIX
$17.4M 0.23%
2,181,101
-224,068
-9% -$3.56M
PNR icon
105
Pentair
PNR
$10.6B
$17.4M 0.23%
239,200
+28,000
+13% +$2.09M
GXO icon
106
GXO Logistics
GXO
$5.8B
$17.3M 0.23%
+220,000
New +$17.3M
CIEN icon
107
Ciena
CIEN
$52.7B
$16.8M 0.22%
327,597
+22,422
+7% +$1.25M
NDAQ icon
108
Nasdaq
NDAQ
$53.2B
$16.6M 0.22%
258,300
+162,600
+170% +$10.2M
XNCR icon
109
Xencor
XNCR
$1.59B
$16.5M 0.22%
506,000
– –
LOB icon
110
Live Oak Bancshares
LOB
$1.97B
$16.5M 0.22%
258,913
+196,213
+313% +$11.6M
BYND icon
111
Beyond Meat
BYND
$286M
$16.1M 0.21%
152,593
– –
ELS icon
112
Equity Lifestyle Properties
ELS
$12.7B
$15.4M 0.2%
196,800
+69,600
+55% +$5.7M
ORIC icon
113
Oric Pharmaceuticals
ORIC
$1.2B
$15.2M 0.2%
724,972
-151,976
-17% -$3.08M
SNPS icon
114
Synopsys
SNPS
$71.3B
$13.7M 0.18%
45,757
+5,000
+12% +$1.52M
SBNY
115
DELISTED
Signature Bank
SBNY
$13.7M 0.18%
50,300
+28,300
+129% +$7.11M
DCPH
116
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$13.6M 0.18%
+400,000
New +$12.8M
AESC
117
DELISTED
The AES Corporation
AESC
$11.9M 0.16%
123,600
+40,400
+49% +$4.1M
FRLN
118
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$11.8M 0.16%
232,377
+66,667
+40% +$4.74M
KALV
119
DELISTED
KalVista Pharmaceuticals
KALV
$11.6M 0.15%
665,681
– –
CRDF icon
120
Cardiff Oncology
CRDF
$66.2M
$11.1M 0.15%
1,670,399
-1,905,435
-53% -$12M
REXR icon
121
Rexford Industrial Realty
REXR
$8.56B
$10.6M 0.14%
+187,600
New +$11.3M
ESI icon
122
Element Solutions
ESI
$8.68B
$10.1M 0.13%
+467,966
New +$10.7M
IEX icon
123
IDEX
IEX
$17.3B
$9.46M 0.12%
45,700
– –
SBAC icon
124
SBA Communications
SBAC
$19.3B
$7.87M 0.1%
23,800
-10,800
-31% -$3.74M
SHW icon
125
Sherwin-Williams
SHW
$83.7B
$7.38M 0.1%
26,400
+14,400
+120% +$4.21M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Eventide Asset Management held 165 positions worth $7.58B, up 1.9% from $7.44B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q3 2021 filing shows 14 new, 52 increased, 27 reduced and 13 closed positions. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,871,612 shares worth $59.2M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $83.1M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2021 buy was DICE Therapeutics, Inc. Common Stock: 1,871,612 shares worth $59.2M.
  • Eventide Asset Management added most to FIVE9 in Q3 2021, an estimated $52.6M increase.
  • Eventide Asset Management's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $83.1M.
  • Eventide Asset Management fully exited BridgeBio Pharma in Q3 2021, selling an estimated $43.4M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $7.58B portfolio in Q3 2021.
  • Eventide Asset Management opened 14 new positions and closed 13 in Q3 2021.
  • Eventide Asset Management's portfolio value rose 1.9% quarter-over-quarter to $7.58B.

Based on Eventide Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.